Rivaroxaban is an oral anticoagulant belonging to the direct factor Xa inhibitor class. It is available as a pill in a 10 mg strength. In Hong Kong, rivaroxaban is a prescription-only medication regulated by the Department of Health. The active ingredient is marketed under various brand names worldwide, including Xarelto®.
Rivaroxaban directly blocks the activity of factor Xa, a key enzyme in the coagulation cascade that converts prothrombin to thrombin. By inhibiting factor Xa, the drug reduces the generation of thrombin and consequently prevents the formation of fibrin clots.
Rivaroxaban is approved by major regulatory agencies (including the U.S. FDA, the European EMA, and Hong Kong’s Department of Health) for several indications. The 10 mg pill is specifically licensed for:
Other approved uses of rivaroxaban (which involve higher strengths) include treatment of deep-vein thrombosis, pulmonary embolism, and stroke prevention in non-valvular atrial fibrillation. Because this article focuses on the 10 mg formulation, dosing details for those indications are not provided here.
Patients with any of the above conditions should discuss alternative strategies with their healthcare provider.
If a patient is taking other medications, supplements, or herbal products, they should inform their prescriber before starting rivaroxaban.
Dosing for other indications (e.g., atrial fibrillation) involves different strengths and regimens; those are beyond the scope of this article.
Regular follow-up visits enable the clinician to adjust therapy based on laboratory results and clinical response.
This article provides educational information about rivaroxaban and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Rivaroxaban may increase bleeding risk when combined with non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen. If occasional use is necessary, acetaminophen is generally safer, but you should discuss any pain-relief plan with your prescriber.
Standard coagulation tests like PT/INR are not reliable for monitoring rivaroxaban. Specific anti-Xa assays can measure its activity, but routine monitoring is rarely required unless there is concern for accumulation (e.g., renal impairment).
Yes, but keep the medication in its original labeled container, carry a copy of the prescription, and be aware of local regulations regarding anticoagulants. Stay hydrated and avoid long periods of immobility to reduce VTE risk.
The 10 mg formulation is approved solely for postoperative VTE prophylaxis. Higher doses (e.g., 15 mg or 20 mg) are used for treatment of established clots or stroke prevention in atrial fibrillation. Each indication follows a distinct dosing schedule determined by the prescriber.
If you realize a missed dose within 12 hours, take it immediately. If more than 12 hours have passed, skip the missed tablet and resume the regular once-daily schedule. Never double-dose to make up for a missed tablet.
Herbal products such as ginkgo biloba, garlic, or ginger have antiplatelet properties and may increase bleeding risk when combined with rivaroxaban. Inform your healthcare provider before using any supplements.
Rivaroxaban does not directly alter blood pressure. However, uncontrolled bleeding can lead to hypotension, and patients with hypertension should continue their antihypertensive regimen as prescribed.
Rivaroxaban provides fixed dosing without routine coagulation monitoring, whereas warfarin requires frequent INR checks and dietary vitamin K restrictions. Rivaroxaban also has fewer drug-food interactions but may be more costly.
Yes, the specific reversal agent andexanet alfa can neutralize the anticoagulant effect of rivaroxaban in emergency situations. Availability may vary by hospital, so discuss options with your care team.
Keep the tablets in a dry place at room temperature, away from direct sunlight or heat sources. If the ambient temperature exceeds 30 °C for extended periods, consider storing the medication in a cooler part of the home, such as a cupboard away from windows.
